|
|
||||||||
The results of this study suggest that the atypical β-adrenergic receptor (β3 subtype) is expressed in human white adipose tissue. A β3-adrenergic receptor mRNA could be detected in human omental fat poly(A)+ RNA by polymerase chain reaction amplification with appropriate primers. The expression of the β3-adrenergic receptor in human fat was confirmed by Northern blot analysis; however, the level of its mRNA was lower than those of the β1- and β2-adrenergic receptors. Two populations of ((–)-4-(3-t-butylamino-2-hydroxypropoxy)-[5,7-3H]benz-imidazole-2-one) ([3H]CGP 12177)-binding sites were identified in human omental fat membranes, one with a high affinity (Kd= 1·7 nM) and the other with a low affinity (Kd = 22 nM). The low affinity binding site population, which should represent the β3-adrenergic receptor, was predominant (75% of the total binding sites).
This article has been cited by other articles:
![]() |
T. M Larsen, S. Toubro, M. A van Baak, K. M Gottesdiener, P. Larson, W. H. Saris, and A. Astrup Effect of a 28-d treatment with L-796568, a novel {beta}3-adrenergic receptor agonist, on energy expenditure and body composition in obese men Am. J. Clinical Nutrition, October 1, 2002; 76(4): 780 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Büettner, A. Schäffler, H. Arndt, G. Rogler, J. Nusser, B. Zietz, I. Enger, S. Hügl, A. Cuk, J. Schölmerich, et al. The Trp64Arg Polymorphism of the {beta} 3-Adrenergic Receptor Gene Is Not Associated with Obesity or Type 2 Diabetes Mellitus in a Large Population-Based Caucasian Cohort J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2892 - 2897. [Abstract] [Full Text] |
||||
![]() |
M. V. Sennitt, A. J. Kaumann, P. Molenaar, L. J. Beeley, P. W. Young, J. Kelly, H. Chapman, S. M. Henson, J. M. Berge, D. K. Dean, et al. The Contribution of Classical (beta 1/2-) and Atypical beta -Adrenoceptors to the Stimulation of Human White Adipocyte Lipolysis and Right Atrial Appendage Contraction by Novel beta 3-Adrenoceptor Agonists of Differing Selectivities J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1084 - 1095. [Abstract] [Full Text] |
||||
![]() |
K. E. Hadri, A. Courtalon, X. Gauthereau, A.-M. Chambaut-Guerin, J. Pairault, and B. Feve Differential Regulation by Tumor Necrosis Factor-alpha of beta 1-, beta 2-, and beta 3-Adrenoreceptor Gene Expression in 3T3-F442A Adipocytes J. Biol. Chem., September 26, 1997; 272(39): 24514 - 24521. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Barbe, V. Stich, J. Galitzky, M. Kunesova, V. Hainer, M. Lafontan, and M. Berlan In Vivo Increase in {beta}-Adrenergic Lipolytic Response in Subcutaneous Adipose Tissue of Obese Subjects Submitted to a Hypocaloric Diet J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 63 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Soloveva, R. A. Graves, M. M. Rasenick, B. M. Spiegelman, and S. R. Ross Transgenic Mice Overexpressing the {beta}1-Adrenergic Receptor in Adipose Tissue Are Resistant to Obesity Mol. Endocrinol., January 1, 1997; 11(1): 27 - 38. [Abstract] [Full Text] |
||||
![]() |
T. Bengtsson, K. Redegren, A. D. Strosberg, J. Nedergaard, and B. Cannon Down-regulation of beta 3 Adrenoreceptor Gene Expression in Brown Fat Cells Is Transient and Recovery Is Dependent upon a Short-lived Protein Factor J. Biol. Chem., December 27, 1996; 271(52): 33366 - 33375. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |